These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28256593)

  • 1. Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation.
    Yost S; de Wolf B; Hanks S; Zachariou A; Marcozzi C; Clarke M; de Voer R; Etemad B; Uijttewaal E; Ramsay E; Wylie H; Elliott A; Picton S; Smith A; Smithson S; Seal S; Ruark E; Houge G; Pines J; Kops GJPL; Rahman N
    Nat Genet; 2017 Jul; 49(7):1148-1151. PubMed ID: 28553959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia.
    Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y
    Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AAA+ ATPase TRIP13 remodels HORMA domains through N-terminal engagement and unfolding.
    Ye Q; Kim DH; Dereli I; Rosenberg SC; Hagemann G; Herzog F; Tóth A; Cleveland DW; Corbett KD
    EMBO J; 2017 Aug; 36(16):2419-2434. PubMed ID: 28659378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary.
    Rosario R; Smith RW; Adams IR; Anderson RA
    Mol Hum Reprod; 2017 Mar; 23(3):177-186. PubMed ID: 28364521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTC5 mediates autoregulation of tubulin via mRNA degradation.
    Lin Z; Gasic I; Chandrasekaran V; Peters N; Shao S; Mitchison TJ; Hegde RS
    Science; 2020 Jan; 367(6473):100-104. PubMed ID: 31727855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
    Mittal K; Cooper GW; Lee BP; Su Y; Skinner KT; Shim J; Jonus HC; Kim WJ; Doshi M; Almanza D; Kynnap BD; Christie AL; Yang X; Cowley GS; Leeper BA; Morton CL; Dwivedi B; Lawrence T; Rupji M; Keskula P; Meyer S; Clinton CM; Bhasin M; Crompton BD; Tseng YY; Boehm JS; Ligon KL; Root DE; Murphy AJ; Weinstock DM; Gokhale PC; Spangle JM; Rivera MN; Mullen EA; Stegmaier K; Goldsmith KC; Hahn WC; Hong AL
    Commun Biol; 2024 Apr; 7(1):426. PubMed ID: 38589567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of renal ischemia reperfusion injury-characteristic genes, pathways and immunological micro-environment features through bioinformatics approaches.
    Lv X; Fan Q; Li X; Li P; Wan Z; Han X; Wang H; Wang X; Wu L; Huo B; Yang L; Chen G; Zhang Y
    Aging (Albany NY); 2024 Feb; 16(3):2123-2140. PubMed ID: 38329418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis.
    Zhang LT; Ke LX; Wu XY; Tian HT; Deng HZ; Xu LY; Li EM; Long L
    Biomed Res Int; 2022; 2022():7295458. PubMed ID: 35601150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity.
    Hama T; Nagesh PK; Chowdhury P; Moore BM; Yallapu MM; Regner KR; Park F
    JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34806647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of β-Catenin/Forkhead Box Protein O Signaling Mediates Epithelial Repair in Kidney Injury.
    Rao P; Qiao X; Hua W; Hu M; Tahan M; Chen T; Yu H; Ren X; Cao Q; Wang Y; Yang Y; Wang YM; Lee VW; Alexander SI; Harris DC; Zheng G
    Am J Pathol; 2021 Jun; 191(6):993-1009. PubMed ID: 33753026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIP13 predicts poor prognosis in clear cell renal cell carcinoma.
    Kowalewski A; Jaworski D; Antosik P; Smolińska M; Ligmanowska J; Grzanka D; Szylberg Ł
    Am J Cancer Res; 2020; 10(9):2909-2918. PubMed ID: 33042625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin Derived Peptide Improved Endoplasmic Reticulum Stress and Ischemia-Reperfusion Related Cellular and Renal Injury.
    Zhang Y; Wang Q; Liu A; Wu Y; Liu F; Wang H; Zhu T; Fan Y; Yang B
    Front Med (Lausanne); 2020; 7():5. PubMed ID: 32039224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into a Crucial Role of TRIP13 in Human Cancer.
    Lu S; Qian J; Guo M; Gu C; Yang Y
    Comput Struct Biotechnol J; 2019; 17():854-861. PubMed ID: 31321001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the cannabinoid receptor 2 increases renal perfusion.
    Pressly JD; Soni H; Jiang S; Wei J; Liu R; Moore BM; Adebiyi A; Park F
    Physiol Genomics; 2019 Mar; 51(3):90-96. PubMed ID: 30707046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid-modified solid lipid nanoparticles as vascular endothelium-targeting carriers for ischemia-reperfusion-induced acute renal injury.
    Hu JB; Song GL; Liu D; Li SJ; Wu JH; Kang XQ; Qi J; Jin FY; Wang XJ; Xu XL; Ying XY; Yu L; You J; Du YZ
    Drug Deliv; 2017 Nov; 24(1):1856-1867. PubMed ID: 29188738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.
    Pressly JD; Mustafa SM; Adibi AH; Alghamdi S; Pandey P; Roy KK; Doerksen RJ; Moore BM; Park F
    J Pharmacol Exp Ther; 2018 Feb; 364(2):287-299. PubMed ID: 29187590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury.
    Pressly JD; Hama T; Brien SO; Regner KR; Park F
    Sci Rep; 2017 Mar; 7():43196. PubMed ID: 28256593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression.
    Yu L; Xiao Y; Zhou X; Wang J; Chen S; Peng T; Zhu X
    Biomed Pharmacother; 2019 Dec; 120():109508. PubMed ID: 31648166
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.